Valneva SE (VALN) Interest & Investment Income (2021 - 2026)

Valneva SE's (VALN) quarterly Interest & Investment Income came in at $615812.2 in Q1 2026, up 14.57% year-on-year from $537512.9 in Q1 2025, and up 120.35% quarter-over-quarter from -$3.0 million in Q4 2025.

Valneva SE (VALN) Interest & Investment Income (2021 - 2026) Analysis & Trends

Valneva SE has disclosed Interest & Investment Income across 6 years of filings, most recently posting $615812.2 for Q1 2026.

  • Interest & Investment Income for Q1 2026 came in at $615812.2, up 14.57% year-over-year; the trailing twelve-month figure through Mar 2026 was $615812.2 (up 14.57% YoY), and the FY2025 annual result was -$3.0 million, down 219.91% from the prior year.
  • Interest & Investment Income came in at $615812.2 for Q1 2026 at Valneva SE, up from -$3.0 million in the prior quarter.
  • In the past five years, Interest & Investment Income ranged from a high of $1.2 million in Q2 2025 to a low of -$3.0 million in Q4 2025.
  • The 5-year median for Interest & Investment Income is $280263.9 (2023), against an average of -$104294.3.
  • Across the five-year window, Interest & Investment Income jumped 1761.19% in 2023 and tumbled 281.15% in 2024, its largest moves.
  • Valneva SE's Interest & Investment Income stood at $59488.2 in 2022, then soared by 1224.87% to $788139.5 in 2023, then sank by 281.15% to -$1.4 million in 2024, then slumped by 111.99% to -$3.0 million in 2025, then surged by 120.35% to $615812.2 in 2026.
  • The last three Interest & Investment Income figures came in at $615812.2 (Q1 2026), -$3.0 million (Q4 2025), and -$2.2 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Int & Inv Inc (Qtr)
1 Alterity Therapeutics 723,416.35 Bn 723,416.32 Bn - 597,319.59
2 Belite Bio 57,340.00 Bn 57,340.00 Bn - -
3 Quantum Biopharma 19,125.08 Bn 19,125.08 Bn - -
4 Legend Biotech 3,262.00 Bn 3,261.71 Bn 242.10 Mn 40.10 Mn
5 Akari Therapeutics 1,789.67 Bn 1,789.67 Bn - -
6 Evaxion A 1,480.39 Bn 1,480.37 Bn - 305,000.00
7 Psyence Biomedical 241.78 Bn 241.78 Bn - 103,341.00
8 Vertex Pharmaceuticals 113.54 Bn 106.29 Bn 2.59 Bn 114.80 Mn
9 Abivax 94.26 Bn 94.26 Bn - -14.79 Mn
10 Valneva SE 167.33 Mn 44.10 Mn 5.08 Mn 615,812.21

Historic Data

Download Data
DateValue
Mar 31, 2026 615,812.21
Dec 31, 2025 -3.03 Mn
Sep 30, 2025 -2.22 Mn
Jun 30, 2025 1.21 Mn
Mar 31, 2025 537,512.95
Sep 30, 2024 -1.43 Mn
Jun 30, 2024 847,510.52
Mar 31, 2024 288,972.23
Sep 30, 2023 788,139.51
Jun 30, 2023 548,817.89
Mar 31, 2023 271,555.48
Sep 30, 2022 59,488.19
Jun 30, 2022 37,346.98
Mar 31, 2022 14,590.39
Sep 30, 2021 283,028.96
Jun 30, 2021 274,573.89
Mar 31, 2021 9.28 Mn